TYK Medicines – Talk Bio

Actionable Insights Powered by AI

TYK Medicines Secures $74M in Hong Kong IPO to Advance EGFR Cancer Therapy

8 months ago talkbio0Tagged EGFR cancer, Hong Kong, IPO, TYK Medicines

TYK Medicines, IPO, EGFR cancer therapy, Hong Kong, biotech funding